A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan
Clinical trial NCT06240741 · COMPLETED
Trial details
- NCT number
- NCT06240741
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-21
- Primary completion
- 2024-12-27
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.